24/7 Customer Support

Japan Pet Cancer Therapeutics Market - Industry Dynamics, Market Size, And Opportunity Forecast To 2031

Japan Pet Cancer Therapeutics Market: By Therapy (Chemotherapy, Immunotherapy, Targeted Therapy, Combination Therapy); By Rout Of Administration (Oral, Injection); By Species (Dogs, Cats, Others); By Application (Lymphoma, Mast Cell Cancer, Melanoma, Mammary and Squamous Cell Cancer); By Distribution Channel (Veterinary Hospitals & Clinical Pharmacies, Online Pharmacies, Retail Pharmacies); By Country—Industry Dynamics, Market Size and Opportunity Forecast till 2031

  • Published Date: 08-Dec-2022  |   Format: pdfpowerpointexcel  |  Report ID: AA1222336
    Delivery: 2 to 4 Hours
INFOGRAPHIC:
Japan Pet Cancer Therapeutics Market

View Full Infographic

FREQUENTLY ASKED QUESTIONS

The market size of the Japan Pet Cancer Therapeutic Market was valued at US$ 14.4 Mn in 2022.

The market is registered to grow at a CAGR of 7.3% during 2023-2031.

Rising adoption of pets and rising number of pet insurance in Japan are the factors triggering growth of the Pet Cancer Therapeutic market. 

Shrinking size of pharma sector in Japan as compared to Western countries are the factors restraining market growth.

Development of new drugs and therapeutic treatment is current trend in the market. 

The various segmentations considered to analyze the Japan Pet Cancer Therapeutic Market are based on therapy, route of administration, species, application, distribution channel.

Rising life expectancies of pet in Japan

Chemotherapy segment dominated the Japan Pet Cancer Therapeutic Market in 2022.

Veterinary Hospitals & Clinical Pharmacies distribution channel held the highest segmental share in 2022.

Lymphoma dominated the Japan Pet Cancer Therapeutic Market in 2022.

Boehringer Ingelheim International GmbH, Zoetis, NIPPON ZENYAKU KOGYO CO., LTD., Sumitomo Pharma Animal Health Co., Elanco Animal Health Incorporated are the key players analyzed in the Japan Pet Cancer Therapeutic market.

The pandemic had a slightly negative impact on the Japan Pet Cancer Therapeutic Market, with a 1.22% drop in Y-O-Y growth of 2019-2020.

LOOKING FOR COMPREHENSIVE MARKET KNOWLEDGE? ENGAGE OUR EXPERT SPECIALISTS.

SPEAK TO AN ANALYST